Table 1.
Composition of the lipid models used in this study
| Model | Lipid Composition | Molar Ratio |
|---|---|---|
| LPP NS:NP 1:2 | CER EOS C30 : CER NS C24 : CER NP C24 : CHOL : FFAC24 | 0.4:0.2:0.4:1:1 |
| LPP NS:NP 1:1 | CER EOS C30 : CER NS C24 : CER NP C24 : CHOL : FFAC24 | 0.4:0.3:0.3:1:1 |
| LPP NS:NP 2:1 | CER EOS C30 : CER NS C24 : CER NP C24 : CHOL : FFAC24 | 0.4:0.4:0.2:1:1 |
| LPP NSd47:NP 1:2 | CER EOS C30 : CER NS C24-d47: CER NP C24 : CHOL : FFAC24 | 0.4:0.2:0.4:1:1 |
| LPP NS:NPd47 1:2 | CER EOS C30 : CER NS C24 : (CER NP C24 : CER NP C24-d47) : CHOL : FFAC24 | 0.4:0.2:(0.2:0.2):1:1 |
| LPP NSd47:NP 2:1 | CER EOS C30 : (CER NS C24 :CER NS C24-d47): CER NP C24 : CHOL : FFAC24 | 0.4:(0.2:0.2):0.2:1:1 |
| LPP NS:NPd47 2:1 | CER EOS C30 : CER NS C24 : CER NP C24-d47: CHOL : FFAC24 | 0.4:0.4:0.2:1:1 |
| LPP NSd47:NP:DFFA 1:2 | CER EOS C30 : CER NS C24-d47: CER NP C24: CHOL: DFFAC24 | 0.4:0.2:0.4:1:1 |
| LPP NS:NPd47:DFFA 1:2 | CER EOS C30 : CER NS C24 : CER NP C24-d47: CHOL: DFFAC24 | 0.4:0.2:0.4:1:1 |
| LPP NSd47:NPd47:DFFA 1:2 | CER EOS C30 : CER NS C24-d47: CER NP C24-d47: CHOL: DFFAC24 | 0.4:0.2:0.4:1:1 |
| LPP NSd47:NP:DFFA 2:1 | CER EOS C30 : CER NS C24-d47: CER NP C24: CHOL: DFFAC24 | 0.4:0.4:0.2:1:1 |
| LPP NS:NPd47:DFFA 2:1 | CER EOS C30 : CER NS C24 : CER NP C24-d47: CHOL: DFFAC24 | 0.4:0.4:0.2:1:1 |
| LPP NSd47:NPd47:DFFA 2:1 | CER EOS C30 : CER NS C24-d47: CER NP C24-d47: CHOL: DFFAC24 | 0.4:0.4:0.2:1:1 |
The deuterated lipids are indicated in bold.